Respiratory tract and lungs and bronchi, percutaneous approach
85815300
Level 3 · Class
Category
16 items in this category
- Exempt
85815304Introduction of analgesics, hypnotics, sedatives into respiratory tract, percutaneous approach - Exempt
85815311Introduction of anti-inflammatory into respiratory tract, percutaneous approach - Exempt
85815301Introduction of destructive agent into respiratory tract, percutaneous approach - Exempt
85815309Introduction of electrolytic and water balance substance into respiratory tract, percutaneous approach - Exempt
85815316Introduction of liquid brachytherapy radioisotope into respiratory tract, percutaneous approach - Exempt
85815308Introduction of local anesthetic into respiratory tract, percutaneous approach - Exempt
85815314Introduction of monoclonal antibody into respiratory tract, percutaneous approach - Exempt
85815303Introduction of nitric oxide gas into respiratory tract, percutaneous approach - Exempt
85815310Introduction of nutritional substance into respiratory tract, percutaneous approach - Exempt
85815312Introduction of other anti-infective into respiratory tract, percutaneous approach - Exempt
85815315Introduction of other antineoplastic into respiratory tract, percutaneous approach - Exempt
85815305Introduction of other diagnostic substance into respiratory tract, percutaneous approach - Exempt
85815302Introduction of other gas into respiratory tract, percutaneous approach - Exempt
85815307Introduction of other therapeutic substance into respiratory tract, percutaneous approach - Exempt
85815313Introduction of oxazolidinones into respiratory tract, percutaneous approach - Exempt
85815306Introduction of radioactive substance into respiratory tract, percutaneous approach